Recent Activities

• Designed computer-aided molecules for small pharma company
• Conducted pre-IND meeting resulting in FDA recommendation of advancement to
  Phase III of an emerging pain therapeutics company
• Raised private seed funding
• Formulated bilayer biphasic drug candidate
• Wrote and submitted successful IND
• Awarded state grant and funding for preclinical studies and formulation of NCE
• Consulted for pan-ocean product approvals

For more information, please contact us.